News
About Sotagliflozin Discovered using Lexicon’s unique approach to gene science, sotagliflozin is an oral inhibitor of two proteins responsible for glucose regulation known as sodium-glucose ...
Lexicon Pharmaceuticals will present study data on sotagliflozin and pilavapadin at the ADA's 85th Scientific Sessions in Chicago.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback